- Hindustan Unilever reported a net income of 25.4 billion rupees for the first quarter of 2024.
- Net income increased by 2.8% year over year but missed the estimated 26.01 billion rupees.
- Revenue for the quarter was 151.7 billion rupees, up 1.6% compared to the previous year.
- Revenue came in lower than the estimated 153.25 billion rupees.
- EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) was 36.1 billion rupees.
- EBITDA increased by 2.6% year over year but fell slightly short of the estimated 36.14 billion rupees.
- The EBITDA margin stood at 23.8%.
- Analyst ratings for Hindustan Unilever include 25 buys, 12 holds, and 5 sells.
A look at Hindustan Unilever Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 5 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Hindustan Unilever appears to have a promising long-term outlook. With a strong dividend score of 5, investors can expect consistent returns from this consumer products manufacturer. The company also scores high in resilience, indicating its ability to weather economic uncertainties and challenges. Furthermore, Hindustan Unilever demonstrates solid momentum and growth potential, with scores of 4 and 3 respectively, suggesting positive movement in the company’s performance and expansion prospects.
Hindustan Unilever Limited, a renowned manufacturer and distributor of consumer products, offers a wide range of everyday essentials such as soap, detergent, personal care items, processed foods, and more. With a global customer base, Hindustan Unilever is positioned as a strong contender in the consumer goods sector, supported by its impressive Smartkarma Smart Scores including high marks for dividend payouts, resilience, momentum, and growth potential.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
